How did Covid affect dementia outcomes?4 answersCOVID-19 infection was associated with an increased risk of dementia, including Alzheimer's disease (AD) and vascular dementia (VaD), during the acute phase (first 30 days). However, the overall dementia risk declined drastically after COVID-19 infection and remained elevated for all-cause dementia, VaD, and other dementia. Among non-hospitalized individuals, elevated dementia risk persisted for all-cause dementia, VaD, and other dementia. The risk of dying was not significantly different between COVID-19 patients with and without dementia, but dementia patients had lower odds of ICU admissions. The pandemic and associated measures, such as quarantine and limited access to healthcare, have had negative effects on the mental and psychological health of elderly individuals with neurocognitive disorders, including MCI and dementia. However, the impact of COVID-19 on dementia patients' psychological state is still inconclusive.
How does fatigue affect cognitive function in individuals recovering from COVID-19?5 answersFatigue has been found to have a negative impact on cognitive function in individuals recovering from COVID-19. Studies have shown that individuals with post-acute sequelae of COVID-19 (PASC) experience persistent symptoms such as mental fatigue, which can affect cognitive flexibility and cognitive performance. Impaired sleep and disrupted rest-activity rhythms, which are common in individuals with PASC, have also been associated with impaired cognitive performance. Additionally, individuals with persistent fatigue following COVID-19 have been found to have lower cognitive function scores, higher depression levels, and sleep disorders. These findings suggest that fatigue can have a detrimental effect on cognitive function in individuals recovering from COVID-19, highlighting the importance of addressing and managing fatigue in the post-COVID-19 population.
What are the neuropsychiatric effects of COVID-19?4 answersThe neuropsychiatric effects of COVID-19 include cognitive impairment ("brain fog"), depression, anxiety, fatigue, insomnia, and mood disturbances. Other manifestations include headache, dizziness, muscle soreness, stroke, seizures, encephalitis, ataxia, myelitis, anosmia, ageusia, Guillain-Barré syndrome, and Miller Fisher syndrome. These effects can persist even after the acute phase of the infection and may be associated with a high risk of suicidal behavior. The mechanisms of these effects involve indirect factors such as cytokine storm, hypoxia, neuroinflammation, and post-infection autoimmunity, as well as possible direct damage to neurons and blood vessels by the virus. Factors such as moderate to severe COVID-19 infection, non-vaccination, and lack of social support increase the risk and severity of these neuropsychiatric manifestations. Monitoring and addressing these neuropsychiatric consequences are crucial for comprehensive COVID-19 treatment and public health management.
Long covid affect cognitive function?5 answersLong COVID can affect cognitive function. Patients with long COVID often experience cognitive deficits, including working memory, motivation, and executive functioning impairments. The dorsolateral prefrontal cortex (dlPFC) is particularly affected, and this may be due to increased levels of kynurenic acid (KYNA) and glutamate carboxypeptidase II (GCPII) in the brain. KYNA blocks neurotransmission in the dlPFC, while GCPII weakens dlPFC network connectivity and reduces neuronal firing. However, there are potential treatment options for these cognitive symptoms. N-acetyl cysteine, an antioxidant, can inhibit KYNA production, and guanfacine, an α2A-adrenoceptor agonist, can regulate dlPFC signaling and reduce inflammation. Additionally, auricular transcutaneous vagus nerve stimulation (atVNS) may be beneficial in compensating for cognitive decline and improving affective symptoms in long COVID patients. Further research is needed to understand the mechanisms underlying cognitive impairment in long COVID and to explore potential therapeutic interventions.
How sleeep devprivation affects the cognitive function of a students after pandemic?5 answersSleep deprivation can have an impact on the cognitive function of students after the pandemic. Studies have shown that lack of sleep due to increased academic demands and the switch to online learning can affect cognitive processes such as inhibitory control and critical thinking. Sleep-deprived individuals may perform worse on cognitive tasks and have difficulty completing them, even though they may perceive their performance to be better than it actually is. Poor sleep quality during the pandemic has been found to be associated with decreased cognitive function in medical students. Additionally, the cognitive flexibility of students has been found to decrease over time during the pandemic, leading to decreased performance on cognitive tasks. Overall, sleep deprivation and poor sleep quality can negatively impact cognitive function in students, affecting their learning and academic performance.
What is the impact of decline of adl over time among persons living with dementia during covid?3 answersThe impact of decline in activities of daily living (ADL) over time among persons living with dementia during the COVID-19 pandemic varied across studies. One study found that COVID-19 had a significant impact on cognitive decline and accelerated decline in the Mini-Mental State Examination (MMSE) score among elderly patients with dementia. Another study reported worries of faster cognitive decline due to lockdown measures, but did not specifically measure the impact on ADL. A study in China found that confinement during the pandemic might ease cognitive and neuropsychiatric deterioration in Alzheimer's disease (AD) patients and help prevent rapid cognitive decline. A study in Italy showed a significant worsening of cognitive decline in people with dementia during the pandemic, suggesting the need for more careful assistance during future lockdowns. Finally, a study on quality of life (QoL) found that QoL did not significantly decline for persons with dementia or their family carers during the pandemic, but there was variation among subgroups.